Related Experiment Video

Updated: May 5, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

12.5K

Natriuretic peptides in unstable coronary artery disease

Tomas Jernberg1, Stefan James, Bertil Lindahl

  • 1Department of Medical Sciences, Cardiology and Uppsala Research Center, Sweden. tomas.jernberg@medsci.uu.se

European Heart Journal
|September 3, 2004
PubMed

Insights

Natriuretic peptides, such as brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP), help predict mortality and heart failure risk in unstable coronary artery disease (CAD). Further research is needed for routine clinical use.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Risk Assessment

Background:

  • Unstable coronary artery disease (CAD) presents diverse clinical scenarios, necessitating early risk stratification for optimal treatment selection.
  • Current risk assessment for unstable CAD relies on established factors, but improved prognostic tools are continually sought.
  • Natriuretic peptides are increasingly recognized for their role in cardiovascular assessment.

Purpose of the Study:

  • To review the emerging role of natriuretic peptides in the early risk assessment of patients with unstable CAD.
  • To evaluate the prognostic value of brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in unstable CAD.
  • To explore the potential utility of these biomarkers in guiding therapeutic decisions.

Main Methods:

  • Systematic review of current literature on natriuretic peptides in unstable CAD.
  • Analysis of studies investigating the association between BNP/NT-proBNP levels and patient outcomes.
  • Evaluation of evidence regarding the impact of natriuretic peptides on treatment selection.

Main Results:

  • Elevated levels of BNP and NT-proBNP are strongly correlated with mortality risk in unstable CAD patients.
  • These natriuretic peptides provide prognostic information independent of traditional risk factors.
  • Evidence suggests potential benefits in guiding therapy, though further validation is required.

Conclusions:

  • BNP and NT-proBNP are valuable prognostic markers for mortality and heart failure risk in unstable CAD.
  • While promising for therapy selection, routine use requires further investigation into cost-effectiveness and clinical impact.
  • Additional studies are essential to confirm the role of natriuretic peptides in guiding treatment strategies for unstable CAD.

More Related Videos

Isolation of Atrial Myocytes from Adult Mice08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

11.7K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K